Non-radiographic Axial Spondyloarthritis (Nr-axSpA)
·MeSH: Non-Radiographic Axial Spondyloarthritis
Prevalence
310.0 / 100K
Incidence
7.3 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Non-radiographic Axial Spondyloarthritis (Nr-axSpA)?
There are 2 clinical trials targeting Non-radiographic Axial Spondyloarthritis (Nr-axSpA) tracked by BioSniper.
What is the prevalence of Non-radiographic Axial Spondyloarthritis (Nr-axSpA)?
The estimated prevalence of Non-radiographic Axial Spondyloarthritis (Nr-axSpA) is approximately 310.0 per 100,000 population.
Deep-dive into Non-radiographic Axial Spondyloarthritis (Nr-axSpA)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis